ロード中...
Post-haematopoietic cell transplantation outcomes: why ST2 became a ‘golden nugget’ biomarker
Immunotherapies have emerged as highly promising approaches to treat cancer patients. Allogeneic haematopoietic cell transplantation (HCT) is the most validated tumour immunotherapy available to date but its clinical efficacy is limited by toxicities, such as graft-versus-host disease (GVHD) and tre...
保存先:
| 出版年: | Br J Haematol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7415515/ https://ncbi.nlm.nih.gov/pubmed/32039480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16497 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|